Keyword: oncology


AbbVie to Buy Cancer Drug Maker ImmunoGen for $10.1 Billion

01.12.2023 -

US biopharma AbbVie has agreed to acquire ImmunoGen in a deal which values the company at about $10.1 billion and gives AbbVie access to flagship cancer therapy Elahere...


FDA Allows Oncology Drug Imports amid Shortage

07.06.2023 -

To boost supply of the injectable chemotherapy drug cisplatin – the US is facing a shortage of oncology treatments – the Food and Drug Administration (FDA) will...


Pfizer Takes Seagen for $43 Billion

15.03.2023 -

Pfizer has agreed to acquire Seagen, a global biotech focused on developing cancer treatments, for $43 billion. The announcement comes just a couple of weeks after the...


Pfizer Doubles Dublin Biologicals Capacity

06.12.2022 -

Pfizer has announced plans to invest more than €1.2 billion at its site in Grange Castle, Dublin, Ireland, to double capacity for biological drug substances.


LG Chem Boosts Oncology Offering with Aveo Buy

21.10.2022 -

South Korea’s LG Chem is to acquire US biopharma Aveo Oncology for an equity value of $566 million. Based in Boston, Massachusetts, Aveo is focused on developing cancer...


Ipsen and Marengo in Cancer Collaboration

08.08.2022 -

French biopharma Ipsen and US-based Marengo Therapeutics have formed a strategic partnership that aims to advance two of Marengo’s preclinical immuno-oncology candidates...


GSK Oncology Chief Moves to Bayer

11.02.2022 -

The pharma industry’s poaching season is on, though some say it’s never off, just taking a break. In the latest drugmaker-to-drugmaker side-swap, among the top news this...


Lilly and Foghorn in Oncology Collaboration

20.12.2021 -

Loxo Oncology at Lilly and Foghorn Therapeutics are collaborating to create novel oncology medicines based on the latter’s Gene Traffic Control platform. Under the terms...